Breaking News
0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

Sanofi France chief sees coronavirus vaccine priced below 10 euros

Stock MarketsSep 06, 2020 08:45AM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters. FILE PHOTO: Sanofi logo is seen at the company's headquarters in Paris, France

PARIS (Reuters) - A coronavirus vaccine that Sanofi (PA:SASY) is developing with Britain's GlaxoSmithKline (L:GSK) is likely to be priced at less than 10 euros ($11.80) per shot if it is approved for use, Sanofi's chief in France said on Saturday.

"The price is not totally set ... We are assessing production costs for the coming months ... We will be below 10 euros," Olivier Bogillot told France Inter radio.

Drugmakers and government agencies are racing to come up with vaccines for the new coronavirus and treatments for COVID-19, the respiratory diseases it causes which has killed more than 879,000 worldwide and wrecked economies.

Asked about rival AstraZeneca (L:AZN), which is expected to price its shot at about 2.50 euros in Europe, Bogillot said: "The price gap for us can be that we use all our internal resources, our own researchers, our own research centres. AstraZeneca outsources part of its production."

A Sanofi spokeswoman said in an emailed statement on Sunday that a final price would only be decided when the vaccine reaches its final testing stage.

"We anticipate being able to determine a final price at the time of our Phase III trials, when we know more about dosing. At this stage, any figure is imprecise. Less than 10 euros is only one of the hypotheses we are working on."

Earlier this week, Sanofi and GSK said they had started a clinical trial of their protein-based coronavirus vaccine candidate, with the ambition of reaching the final testing stage, also known as Phase III, by December.

If the results are positive, Sanofi and GSK hope to get the vaccine approved in the first half of next year.

Sanofi is also working on another coronavirus vaccine candidate with U.S group Translate Bio (O:TBIO) that will use another technology known as messenger RNA.

Sanofi France chief sees coronavirus vaccine priced below 10 euros
 

Related Articles

Ant leapfrogs banks to top China fund sale rankings
Ant leapfrogs banks to top China fund sale rankings By Reuters - May 14, 2021

By Andrew Galbraith and Samuel Shen SHANGHAI (Reuters) - Alibaba (NYSE:BABA) affiliate Ant Group became China's largest seller of non-money-market mutual funds in the first...

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email